title: [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
authors.affiliation: ANMCO-Area Scompenso Cardiaco, Firenze.
authors.forename: G
authors.initials: G
authors.lastname: Sinagra
authors.forename: A
authors.initials: A
authors.lastname: Boccanelli
authors.forename: F
authors.initials: F
authors.lastname: Camerini
authors.forename: A
authors.initials: A
authors.lastname: Gavazzi
authors.forename: E
authors.initials: E
authors.lastname: Gronda
authors.forename: A P
authors.initials: AP
authors.lastname: Maggioni
authors.forename: C
authors.initials: C
authors.lastname: Opasich
authors.forename: C
authors.initials: C
authors.lastname: Rapezzi
authors.forename: M
authors.initials: M
authors.lastname: Scherillo
authors.forename: L
authors.initials: L
authors.lastname: Tavazzi
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D017298:Bisoprolol / Q000008:administration & dosage / Q000627:therapeutic use; D002227:Carbazoles / Q000008:administration & dosage / Q000627:therapeutic use; D000077261:Carvedilol; D018849:Controlled Clinical Trials as Topic; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage / Q000627:therapeutic use; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol; D008790:Metoprolol; D017298:Bisoprolol
vernacular_title: Betabloccanti nello scompenso cardiaco. Esperienze e suggerimenti per l'impiego clinico. ANMCO-Area Scompenso Cardiaco.